Three Months Ended December 31,

Three Months Ended March 31,

Three Months Ended June 30,

Revenue

2011

2010

Change

2012

2011

Change

2012

2011

Change

Pharmaceutical Distribution

$

20,134,050

$

19,778,084

2%

$

19,757,210

$

19,652,364

1%

$

19,372,722

$

20,036,062

(3)%

Other

258,061

120,398

114%

357,696

122,520

192%

453,701

140,100

224%

Intersegment eliminations

(31,466

)

(9,873

)

219%

(43,635

)

(14,627

)

198%

(57,039

)

(15,140

)

277%

Revenue

$

20,360,645

$

19,888,609

2%

$

20,071,271

$

19,760,257

2%

$

19,769,384

$

20,161,022

(2)%

Three Months Ended December 31,

Three Months Ended March 31,

Three Months Ended June 30,

Operating Income

2011

2010

Change

2012

2011

Change

2012

2011

Change

Pharmaceutical Distribution

$

276,385

$

268,148

3%

$

350,021

$

346,894

1%

$

295,296

$

304,877

(3)%

Other

12,088

8,618

40%

27,107

18,355

48%

23,243

12,282

89%

Employee severance, litigation and other

(3,559

)

—

N/M

(9,027

)

—

N/M

(4,844

)

—

N/M

Operating income

$

284,914

$

276,766

3%

$

368,101

$

365,249

1%

$

313,695

$

317,159

(1)%

Percentages of revenue:

Pharmaceutical Distribution

Gross profit

2.74%

2.78%

3.22%

3.30%

3.06%

3.08%

Operating expenses

1.37%

1.43%

1.44%

1.53%

1.53%

1.56%

Operating income

1.37%

1.36%

1.77%

1.77%

1.52%

1.52%

Other

Gross profit

15.67%

24.49%

16.70%

32.42%

21.30%

25.65%

Operating expenses

10.98%

17.34%

9.12%

17.44%

16.18%

16.88%

Operating income

4.68%

7.16%

7.58%

14.98%

5.12%

8.77%

AmerisourceBergen Corporation

Gross profit

2.91%

2.92%

3.46%

3.48%

3.49%

3.24%

Operating expenses

1.51%

1.53%

1.63%

1.63%

1.90%

1.67%

Operating income

1.40%

1.39%

1.83%

1.85%

1.59%

1.57%